Overview

Study of the Effects of Itraconazole and Carbamazepine on LY3410738 in Healthy Participants

Status:
Recruiting
Trial end date:
2022-05-30
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to learn about how itraconazole and carbamazepine affect the levels of LY3410738 in the blood stream of healthy participants. Participation could last up to 75 days.
Phase:
Phase 1
Details
Lead Sponsor:
Eli Lilly and Company
Collaborator:
Loxo Oncology, Inc.
Treatments:
Carbamazepine
Itraconazole